Most cited article(s)

  • Late results of coronary bypass in patients with peripheral vascular disease
    Norman R. Hertzer, M.D., Jess R. Young, M.D., Edwin G. Bevett, M.D., Patrick J. O’Hara, M.D., Robert A. Graor, M.D., William F. Ruschhaupt, M.D. and Linda C. Maljovec, B.A.
    Cleveland Clinic Journal of Medicine January 1987, 54 (1) 15-23;
  • Approach to asymptomatic creatine kinase elevation
    Siamak Moghadam-Kia, MD, Chester V. Oddis, MD and Rohit Aggarwal, MD, MS
    Cleveland Clinic Journal of Medicine January 2016, 83 (1) 37-42; DOI: https://doi.org/10.3949/ccjm.83a.14120

    Standard cutoffs may be too low. First, repeat the test after 7 days without exercise.

  • Respiratory tract infections: Another reason not to smoke
    Susan Murin, MD, MSc and Kathryn Smith Bilello, MD
    Cleveland Clinic Journal of Medicine October 2005, 72 (10) 916-920;

    Patients who smoke need to be informed about the benefits of being vaccinated and stopping smoking.

  • Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
    Federico Perez, MD and David Van Duin, MD, PhD
    Cleveland Clinic Journal of Medicine April 2013, 80 (4) 225-233; DOI: https://doi.org/10.3949/ccjm.80a.12182

    The emergence of carbapenem-resistant Enterobacteriaceae (CRE) highlights the importance of effective antibiotics to maintain the safety of our health care system. Clinicians will encounter CRE as a cause of difficult-to-treat and often fatal infections in hospitalized patients. We review the mechanisms of carbapenem resistance, the dissemination and clinical impact of these resistant organisms, and challenges to their detection, treatment, and control.

  • Heart failure in African Americans: Disparities can be overcome
    Alok Sharma, MD, Monica Colvin-Adams, MD, MS and Clyde W. Yancy, MD, MSc
    Cleveland Clinic Journal of Medicine May 2014, 81 (5) 301-311; DOI: https://doi.org/10.3949/ccjm.81a.13045

    African Americans are disproportionately affected by heart failure, but discrepant outcomes can be minimized.

  • Cardiac amyloidosis: An update on diagnosis and treatment
    Joseph P. Donnelly, MD and Mazen Hanna, MD
    Cleveland Clinic Journal of Medicine December 2017, 84 (12 suppl 3) 12-26; DOI: https://doi.org/10.3949/ccjm.84.s3.02
  • Doppler echocardiographic assessment of constrictive pericarditis, cardiac amyloidosis, and cardiac tamponade
    Allan L. Klein, MD and Gerald I. Cohen, MD
    Cleveland Clinic Journal of Medicine May 1992, 59 (3) 278-290;

    Doppler echocardiography is emerging as an excellent noninvasive way to assess diastolic function, and its array of clinical applications is expanding.

  • The STAR*D study: Treating depression in the real world
    Bradley N. Gaynes, MD, MPH, A. John Rush, MD, Madhukar H. Trivedi, MD, Stephen R. Wisniewski, PhD, Donald Spencer, MD, MBA and Maurizio Fava, MD
    Cleveland Clinic Journal of Medicine January 2008, 75 (1) 57-66;

    This study found that depression can be treated successfully by primary care physicians under real-world conditions. The particular drug or drugs used are not as important as a rational plan.

  • C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging
    Irving Kushner, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 535-537;

    CRP elevations are a sensitive test for inflammation, hut are not specific.

  • Home monitoring for COVID-19
    Michelle Medina, MD, Christopher Babiuch, MD, Michelle Card, MSN, RN-BC, CCCTM, Ruthann Gavrilescu, MSN, MEd, RN, William Zafirau, MD, Eric Boose, MD, Kimberly Giuliano, MD, Alice Kim, MD, Robert Jones, MD and Adrienne Boissy, MD
    Cleveland Clinic Journal of Medicine June 2020, DOI: https://doi.org/10.3949/ccjm.87a.ccc028

Pages